Eversana expands North American reach, pens deal for Accelera Canada
Acquisition is centered on market access and patient advocacy
Eversana, a provider of global commercial services to the life sciences industry, has acquired Accelera Canada, along with its partner companies Patient Access Solutions, Podium Strategic Partners, Inc. and Advocacy Solutions. Based in Toronto, Accelera Canada is an end-to-end commercialization service provider that is helping 50 companies operate in the Canadian pharma market. Financial terms of the deal were not disclosed, but with this latest development, Eversana is able to expand its Canada-based team.
“We are rapidly scaling our global commercialization services by finding and partnering with the best service providers in every region,” says Jim Lang, Eversana’s CEO. “The Accelera Canada team adds decades of experience navigating the fields of product launch, market access and patient advocacy in the Canadian marketplace, making them the perfect partner to support the growing needs of our clients.”
Accelera Canada’s founding partners and owners, Michael Cloutier, Charles Pirraglia, Deborah Brown, Lindy Forte and Ryan Clarke, as well as extended team members, will join Eversana immediately. And over the next few months, legacy brands will be integrated.
